Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19 and hypoxemia Part II: Causal inference using the Bradford Hill criteria

Released on J-STAGE: March 25, 2025 | Volume 78 Issue 1 Pages 35-68

Eleftherios Gkioulekas, Ph.D., Peter A. McCullough, M.D., M.P.H., Colleen Aldous, Ph.D.

Global trends in clinical studies of ivermectin in COVID-19

Released on J-STAGE: June 13, 2024 | Volume 74 Issue 1 Pages 1-43

Morimasa Yagisawa, Ph.D., Patrick J. Foster, M.D., Hideaki Hanaki, Ph.D., Satoshi Ōmura, Ph.D.

Historical and hygienic aspects on roles of quality requirements for antibiotic products in Japan: Part 9—Integration of the “Requirements for Antibiotic Products of Japan” into the “Japanese Pharmacopoeia”

Released on J-STAGE: June 20, 2024 | Volume 72 Issue 2 Pages 157-171

Morimasa Yagisawa, Patrick J. Foster, Tatsuo Kurokawa

Global trends in clinical trials of ivermectin for COVID-19—Part 2

Released on J-STAGE: March 28, 2024 | Volume 77 Issue 1 Pages 45-92

Morimasa Yagisawa, Ph.D., Patrick J. Foster, M.D., Hideaki Hanaki, Ph.D., Satoshi Ōmura, Ph.D.

Japan’s relapsing fever chronicles

Released on J-STAGE: June 25, 2025 | Volume 78 Issue 2 Pages 69-93

Morimasa Yagisawa, Yukiko Takarabe, Hidehito Matsui, Patrick J. Foster